284 related articles for article (PubMed ID: 28473226)
1. Kennedy disease (X-linked recessive bulbospinal neuronopathy): A comprehensive review from pathophysiology to therapy.
Querin G; Sorarù G; Pradat PF
Rev Neurol (Paris); 2017 May; 173(5):326-337. PubMed ID: 28473226
[TBL] [Abstract][Full Text] [Related]
2. Perspectives of Kennedy's disease.
Finsterer J
J Neurol Sci; 2010 Nov; 298(1-2):1-10. PubMed ID: 20846673
[TBL] [Abstract][Full Text] [Related]
3. Onset Manifestations of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease).
Finsterer J; Soraru G
J Mol Neurosci; 2016 Mar; 58(3):321-9. PubMed ID: 26482145
[TBL] [Abstract][Full Text] [Related]
4. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease.
Breza M; Koutsis G
J Neurol; 2019 Mar; 266(3):565-573. PubMed ID: 30006721
[TBL] [Abstract][Full Text] [Related]
5. Bulbar and spinal muscular atrophy (Kennedy's disease): a review.
Finsterer J
Eur J Neurol; 2009 May; 16(5):556-61. PubMed ID: 19405197
[TBL] [Abstract][Full Text] [Related]
6. Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice.
Gray AL; Annan L; Dick JRT; La Spada AR; Hanna MG; Greensmith L; Malik B
Dis Model Mech; 2020 May; 13(5):. PubMed ID: 32152060
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathophysiology and disease-modifying therapies for spinal and bulbar muscular atrophy.
Katsuno M; Banno H; Suzuki K; Adachi H; Tanaka F; Sobue G
Arch Neurol; 2012 Apr; 69(4):436-40. PubMed ID: 22158719
[TBL] [Abstract][Full Text] [Related]
8. X-linked SBMA model mice display relevant non-neurological phenotypes and their expression of mutant androgen receptor protein in motor neurons is not required for neuromuscular disease.
Gromova A; Cha B; Robinson EM; Strickland LM; Nguyen N; ElMallah MK; Cortes CJ; La Spada AR
Acta Neuropathol Commun; 2023 Jun; 11(1):90. PubMed ID: 37269008
[TBL] [Abstract][Full Text] [Related]
9. Introduction to the Special Issue on Spinal and Bulbar Muscular Atrophy.
Pennuto M; Gozes I
J Mol Neurosci; 2016 Mar; 58(3):313-6. PubMed ID: 26875173
[TBL] [Abstract][Full Text] [Related]
10. The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.
Pradat PF; Bernard E; Corcia P; Couratier P; Jublanc C; Querin G; Morélot Panzini C; Salachas F; Vial C; Wahbi K; Bede P; Desnuelle C;
Orphanet J Rare Dis; 2020 Apr; 15(1):90. PubMed ID: 32276665
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Clinical, Electrodiagnostic and Muscle Pathology Features of Spinal and Bulbar Muscular Atrophy.
Jokela ME; Udd B
J Mol Neurosci; 2016 Mar; 58(3):330-4. PubMed ID: 26572533
[TBL] [Abstract][Full Text] [Related]
12. [Two brothers with very late onset of muscle weakness in X-linked recessive spinal and bulbar muscular atrophy].
Hemmi S; Inoue K; Kutoku Y; Rikimaru M; Murakami T; Sunada Y
Rinsho Shinkeigaku; 2009 Jan; 49(1):22-6. PubMed ID: 19227892
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease.
Arnold FJ; Merry DE
Neurotherapeutics; 2019 Oct; 16(4):928-947. PubMed ID: 31686397
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations and AR gene mutations in Kennedy's disease.
Liu X; Zhu M; Li X; Tang J
Funct Integr Genomics; 2019 May; 19(3):533-539. PubMed ID: 30612224
[TBL] [Abstract][Full Text] [Related]
15. X-linked spinal and bulbar muscular atrophy (Kennedy's disease): the first case described in the Brazilian Amazon.
Alves CN; Braga TKK; Somensi DN; Nascimento BSVD; Lima JAS; Fujihara S
Einstein (Sao Paulo); 2018 Jun; 16(2):eRC4011. PubMed ID: 29898093
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA).
Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G
Cell Tissue Res; 2012 Jul; 349(1):313-20. PubMed ID: 22476656
[TBL] [Abstract][Full Text] [Related]
17. Metabolic alterations in spinal and bulbar muscular atrophy.
Francini-Pesenti F; Vitturi N; Tresso S; Sorarù G
Rev Neurol (Paris); 2020 Dec; 176(10):780-787. PubMed ID: 32631678
[TBL] [Abstract][Full Text] [Related]
18. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR
Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330
[TBL] [Abstract][Full Text] [Related]
19. Kennedy's disease and partial androgen insensitivity syndrome. Report of 4 cases and literature review.
Valera Yepes R; Virgili Casas M; Povedano Panades M; Guerrero Gual M; Villabona Artero C
Endocrinol Nutr; 2015 May; 62(5):224-30. PubMed ID: 25857692
[TBL] [Abstract][Full Text] [Related]
20. New routes to therapy for spinal and bulbar muscular atrophy.
Rocchi A; Pennuto M
J Mol Neurosci; 2013 Jul; 50(3):514-23. PubMed ID: 23420040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
